Anti PD-1 monoclonal antibody induced autoimmune diabetes mellitus: a case report and brief review

Nowadays, immune checkpoint inhibitor therapy has been used in more and more cancer patients. These agents were associated with immune-related adverse effects, and autoimmune diabetes mellitus is one of them. And it is not common but can be potentially fatal. Anti PD-1 monoclonal antibody is a human...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Wang, Hao, Chen, Bin, Zhao, Sha, Zhang, Xiaoshen, Jia, Keyi, Deng, Juan, He, Yayi, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225154/
https://www.ncbi.nlm.nih.gov/pubmed/32420079
http://dx.doi.org/10.21037/tlcr.2020.03.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225154/
https://www.ncbi.nlm.nih.gov/pubmed/32420079
http://dx.doi.org/10.21037/tlcr.2020.03.05

Ejemplares similares